Keyphrases
YB-1
100%
Oncolytic Adenovirus
85%
Adenovirus
57%
Virotherapy
37%
Virus
33%
Ribozyme
33%
Oncolytic Virus
31%
Bladder Cancer
27%
Tumor
26%
Cyclin-dependent Kinase 4 (CDK4)
24%
Adenoviral
19%
Oncolytic Virotherapy
18%
Multidrug Resistance Protein 1 (MDR1)
18%
Hammerhead Ribozyme
18%
Glioblastoma
18%
Tumor Cells
15%
Oncolytic
15%
Viral Replication
15%
Cancer Cells
11%
High Activity
11%
Human Sodium Iodide Symporter (hNIS)
11%
P-glycoprotein (P-gp)
11%
Gene Expression
11%
Tumor Growth
11%
Gene Therapy
11%
Dendrimer
10%
Ewing Sarcoma
10%
Radiovirotherapy
10%
ATP-binding Cassette Transporter A1 (ABCA1)
10%
Multidrug Resistance
10%
Resistant Cancer Cells
10%
Infected Cells
10%
Retinoblastoma
9%
Magnetic Nanoparticles
9%
Flap
9%
Intranasal Delivery
9%
Glypican-3 (GPC3)
9%
Theranostics
9%
Conditionally Replicating Adenovirus
9%
NIS Gene
9%
Adenovirus Vector
9%
Cancer Cell Killing
9%
Temozolomide
8%
Adenoviral Vector
8%
Palbociclib
8%
Oncolytic Potency
8%
Germany
8%
Therapeutic Effect
8%
In Cancer
7%
Transcription Factor
7%
Medicine and Dentistry
Oncolytic Adenovirus
60%
Neoplasm
33%
Virotherapy
30%
Y Box Binding Protein 1
30%
Oncolytic Virus
30%
In Vitro
27%
Ribozyme
26%
Adenoviridae
24%
Oncolytic Virotherapy
23%
Bladder Cancer
22%
Cancer Cell
21%
Virus
20%
Glioblastoma
16%
Tumor Cell
15%
Messenger RNA
14%
Cell Killing
12%
T Cell
11%
Xenograft
11%
Ewing Sarcoma
10%
Ganglioglioma
10%
Malignant Neoplasm
10%
Multidrug Resistance
9%
Vasculotropin
9%
Retinoblastoma
9%
Gene Therapy
9%
Intracranial Tumor
9%
ABC Transporter Subfamily B
8%
Hammerhead Ribozyme
8%
Cell Line
8%
Therapy Effect
8%
Conditionally Replicating Adenovirus
8%
Short Hairpin RNA
8%
Tumor Progression
7%
Adenovirus Vector
7%
CDK4/6 Inhibitor
7%
Necrosis
7%
Intranasal Drug Administration
7%
Clinical Trial
7%
Indocyanine Green
7%
Gene Transfer
6%
Carcinoma Cell
6%
Ganciclovir
6%
Transitional Cell Carcinoma
6%
Cell Proliferation
6%
Mitogen-Activated Protein Kinase
6%
Fluoroscopy
6%
Abscopal Effect
5%
Immunosuppressive Drug
5%
Breast Cancer
5%
Bladder
5%
Immunology and Microbiology
Oncolytic Adenovirus
73%
Virotherapy
55%
Adenoviridae
51%
Virus
41%
Y Box Binding Protein 1
40%
Cancer Cell
32%
Oncolytic Virus
25%
Viral Replication
20%
Tumor Cell
18%
Promoter Region
17%
Adenovirus Vector
17%
Xenograft
16%
Mouse Model
16%
Multidrug Resistance
13%
Cell Killing
12%
Conditionally Replicating Adenovirus
11%
T Cell
11%
Vasculotropin
10%
Multidrug Resistance Protein 1
10%
Gene Expression
10%
Cotransporter
9%
Sodium Iodide
9%
Cancer Stem Cell
9%
DNA Synthesis
9%
P-Glycoprotein
9%
Cell Line
9%
Virus Release
8%
Cell Death
8%
Cytolysis
7%
Gene Transfer
6%
Carcinoma Cell
6%
down Regulation
6%
Antineoplastic Activity
6%
Viral Disease
6%
Tumor Gene
6%
Cell Proliferation
6%
Preclinical Study
6%
Neutralizing Antibody
5%
Nude Mouse
5%
DNA Virus
5%
Immunosuppressive Drug
5%
Glioma Cell
5%
Cytopathic Effect
5%
Transactivation
5%
